Company Filing History:
Years Active: 2000-2003
Title: Alberto Umile: Innovator in Cardiovascular Therapy
Introduction
Alberto Umile is a notable inventor based in Parma, Italy. He has made significant contributions to the field of cardiovascular therapy, holding a total of 3 patents. His work focuses on innovative treatments for left ventricular dysfunction, showcasing his dedication to improving patient outcomes.
Latest Patents
Umile's latest patents include groundbreaking methods for treating cardiovascular diseases. One of his inventions, titled "Aminotetralin derivatives for the therapy of cardiovascular diseases," relates to a method of treatment for left ventricular dysfunction. This method involves administering a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof, to subjects suffering from left ventricular remodeling. Another patent, "Aminotetralin derivative for the therapy of cardiovascular diseases," outlines a process that combines the administration of these compounds with an angiotensin-converting enzyme inhibitor to enhance treatment efficacy.
Career Highlights
Throughout his career, Umile has worked with prominent companies in the pharmaceutical industry, including Chiesi Farmaceutici S.p.a. and Chiesi Pharmaceuticals S.p.a. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Umile has collaborated with talented professionals in his field, including Stefano Bongrani and Roberta Razzetti. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Alberto Umile's contributions to cardiovascular therapy through his patents and collaborations highlight his commitment to innovation in medicine. His work continues to pave the way for new treatment options, ultimately benefiting patients with cardiovascular diseases.